Application
WB analysis of extracts from various cell lines using HNMT antibody.Application
IHC-P analysis of human thyroid cancer using HNMT antibody at a dilution of 1:200.Application
IHC-P analysis of human breast cancer using HNMT antibody at a dilution of 1:200.Application
IHC-P analysis of human kidney cancer using HNMT antibody at a dilution of 1:200.Application
IHC-P analysis of human stomach cancer using HNMT antibody at a dilution of 1:200.Application
ICC/IF analysis of U2OS cells using HNMT antibody (green) and DAPI (blue).| Product Name | HNMT antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to HNMTIn mammals, histamine is metabolized by two major pathways: N(tau)-methylation via histamine N-methyltransferase and oxidative deamination via diamine oxidase. This gene encodes the first enzyme which is found in the cytosol and uses S-adenosyl-L-methionine as the methyl donor. In the mammalian brain, the neurotransmitter activity of histamine is controlled by N(tau)-methylation as diamine oxidase is not found in the central nervous system. A common genetic polymorphism affects the activity levels of this gene product in red blood cells. Multiple alternatively spliced transcript variants that encode different proteins have been found for this gene. [provided by RefSeq, Jul 2008] |
| Immunogen | Recombinant protein of human HNMT |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHC-PWB |
| WB: 1:500 - 1:200. IHC: 1:50 - 1:20. IF: 1:50 - 1:200: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | HMT HNMT-S2 HNMT-S1 histamine N-methyltransferase |
|---|---|
| Target | HNMT |
| Molecular Weight(MW) | 33 kDa (note) |
Application
WB analysis of extracts from various cell lines using HNMT antibody.
Application
IHC-P analysis of human thyroid cancer using HNMT antibody at a dilution of 1:200.
Application
IHC-P analysis of human breast cancer using HNMT antibody at a dilution of 1:200.
Application
IHC-P analysis of human kidney cancer using HNMT antibody at a dilution of 1:200.
Application
IHC-P analysis of human stomach cancer using HNMT antibody at a dilution of 1:200.
Application
ICC/IF analysis of U2OS cells using HNMT antibody (green) and DAPI (blue).| Application Notes | WB: 1:500 - 1:200. IHC: 1:50 - 1:20. IF: 1:50 - 1:200: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20°C (regular) or -80°C (long term). Avoid freeze / thaw cycles. |
| Storage Buffer | PBS with 0.02% sodium azide, 50% glycerol, pH7.3. |
